| 0 |
DRUG INEFFECTIVE |
36 |
| 1 |
HYPOTENSION |
30 |
| 2 |
HYPOXIA |
27 |
| 3 |
VENTILATION PERFUSION MISMATCH |
25 |
| 4 |
OXYGEN SATURATION DECREASED |
18 |
| 5 |
TACHYCARDIA |
17 |
| 6 |
ATRIAL FIBRILLATION |
15 |
| 7 |
BRADYCARDIA |
13 |
| 8 |
EXTRAVASATION |
13 |
| 9 |
BLOOD PRESSURE INADEQUATELY CONTROLLED |
11 |
| 10 |
OFF LABEL USE |
11 |
| 11 |
INFUSION SITE EXTRAVASATION |
10 |
| 12 |
BLOOD TRIGLYCERIDES INCREASED |
9 |
| 13 |
DRUG ADMINISTRATION ERROR |
9 |
| 14 |
NO ADVERSE EVENT |
8 |
| 15 |
ACUTE KIDNEY INJURY |
7 |
| 16 |
HYPERTRIGLYCERIDAEMIA |
7 |
| 17 |
PYREXIA |
7 |
| 18 |
BLOOD PRESSURE INCREASED |
6 |
| 19 |
CEREBRAL HAEMORRHAGE |
6 |
| 20 |
HYPERTENSIVE CRISIS |
6 |
| 21 |
ILEUS |
6 |
| 22 |
MENTAL STATUS CHANGES |
6 |
| 23 |
BLOOD PRESSURE DECREASED |
5 |
| 24 |
HEART RATE INCREASED |
5 |
| 25 |
HYPERTENSION |
5 |
| 26 |
NAUSEA |
5 |
| 27 |
POST PROCEDURAL COMPLICATION |
5 |
| 28 |
PRODUCT COMPLAINT |
5 |
| 29 |
PRODUCT LABEL ISSUE |
5 |
| 30 |
TREATMENT FAILURE |
5 |
| 31 |
ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS |
4 |
| 32 |
CARDIAC FAILURE |
4 |
| 33 |
DEATH |
4 |
| 34 |
ELECTROCARDIOGRAM QT PROLONGED |
4 |
| 35 |
ENCEPHALOPATHY |
4 |
| 36 |
HAEMOLYSIS |
4 |
| 37 |
HYPERLIPIDAEMIA |
4 |
| 38 |
INFUSION SITE SWELLING |
4 |
| 39 |
PRODUCT USE IN UNAPPROVED INDICATION |
4 |
| 40 |
PULMONARY CONGESTION |
4 |
| 41 |
RASH |
4 |
| 42 |
RESPIRATORY DISTRESS |
4 |
| 43 |
RESPIRATORY FAILURE |
4 |
| 44 |
RESPIRATORY GAS EXCHANGE DISORDER |
4 |
| 45 |
ANAEMIA |
3 |
| 46 |
ANGIOEDEMA |
3 |
| 47 |
APHASIA |
3 |
| 48 |
CEREBROVASCULAR ACCIDENT |
3 |
| 49 |
CONDITION AGGRAVATED |
3 |
| 50 |
DELIRIUM |
3 |
| 51 |
DEPRESSED LEVEL OF CONSCIOUSNESS |
3 |
| 52 |
DRUG INTERACTION |
3 |
| 53 |
DYSPHAGIA |
3 |
| 54 |
DYSPNOEA |
3 |
| 55 |
EPISTAXIS |
3 |
| 56 |
FEBRILE NEUTROPENIA |
3 |
| 57 |
GENERAL PHYSICAL HEALTH DETERIORATION |
3 |
| 58 |
INFUSION RELATED REACTION |
3 |
| 59 |
LIPASE INCREASED |
3 |
| 60 |
NO THERAPEUTIC RESPONSE |
3 |
| 61 |
PANCREATITIS |
3 |
| 62 |
PERICARDIAL EFFUSION |
3 |
| 63 |
PLEURAL EFFUSION |
3 |
| 64 |
PO2 DECREASED |
3 |
| 65 |
PRODUCT QUALITY ISSUE |
3 |
| 66 |
PULMONARY OEDEMA |
3 |
| 67 |
SEIZURE |
3 |
| 68 |
THERAPY NON-RESPONDER |
3 |
| 69 |
UNRESPONSIVE TO STIMULI |
3 |
| 70 |
URTICARIA |
3 |
| 71 |
ACUTE MYELOID LEUKAEMIA |
2 |
| 72 |
AORTIC DISSECTION |
2 |
| 73 |
ARRHYTHMIA |
2 |
| 74 |
ARTERIAL HAEMORRHAGE |
2 |
| 75 |
BLOOD AMYLASE INCREASED |
2 |
| 76 |
BLOOD CREATININE INCREASED |
2 |
| 77 |
BLOOD GLUCOSE INCREASED |
2 |
| 78 |
BLOOD PRESSURE SYSTOLIC INCREASED |
2 |
| 79 |
BLOOD TEST ABNORMAL |
2 |
| 80 |
CARDIAC ARREST |
2 |
| 81 |
CARDIOGENIC SHOCK |
2 |
| 82 |
CARDIOMEGALY |
2 |
| 83 |
CEREBRAL INFARCTION |
2 |
| 84 |
CEREBRAL MASS EFFECT |
2 |
| 85 |
COGNITIVE DISORDER |
2 |
| 86 |
DEEP VEIN THROMBOSIS |
2 |
| 87 |
DIARRHOEA |
2 |
| 88 |
DRUG TITRATION ERROR |
2 |
| 89 |
ELECTROENCEPHALOGRAM ABNORMAL |
2 |
| 90 |
GASTROINTESTINAL HAEMORRHAGE |
2 |
| 91 |
GINGIVAL BLEEDING |
2 |
| 92 |
HAEMOGLOBIN DECREASED |
2 |
| 93 |
HAEMORRHAGE INTRACRANIAL |
2 |
| 94 |
HEART RATE DECREASED |
2 |
| 95 |
HYPOVOLAEMIC SHOCK |
2 |
| 96 |
INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION |
2 |
| 97 |
INCORRECT DOSE ADMINISTERED |
2 |
| 98 |
INFECTION SUSCEPTIBILITY INCREASED |
2 |
| 99 |
INFUSION SITE ERYTHEMA |
2 |
| 100 |
KETOACIDOSIS |
2 |
| 101 |
LEFT VENTRICULAR HYPERTROPHY |
2 |
| 102 |
MYOCARDIAL INFARCTION |
2 |
| 103 |
NEPHROPATHY TOXIC |
2 |
| 104 |
NEUROTOXICITY |
2 |
| 105 |
NEUTROPENIA |
2 |
| 106 |
PAIN |
2 |
| 107 |
PANCYTOPENIA |
2 |
| 108 |
PENILE HAEMORRHAGE |
2 |
| 109 |
PERIODONTITIS |
2 |
| 110 |
PETECHIAE |
2 |
| 111 |
PNEUMONIA |
2 |
| 112 |
POSTOPERATIVE DELIRIUM |
2 |
| 113 |
PREMATURE RECOVERY FROM ANAESTHESIA |
2 |
| 114 |
PRESCRIBED OVERDOSE |
2 |
| 115 |
PRODUCT CONTAMINATION PHYSICAL |
2 |
| 116 |
PRODUCT LABEL CONFUSION |
2 |
| 117 |
PULMONARY ALVEOLAR HAEMORRHAGE |
2 |
| 118 |
PULMONARY EMBOLISM |
2 |
| 119 |
RENAL FAILURE |
2 |
| 120 |
RENAL FAILURE ACUTE |
2 |
| 121 |
RENAL IMPAIRMENT |
2 |
| 122 |
RHINITIS |
2 |
| 123 |
SEPSIS |
2 |
| 124 |
SHUNT BLOOD FLOW EXCESSIVE |
2 |
| 125 |
SINUS TACHYCARDIA |
2 |
| 126 |
SUBARACHNOID HAEMORRHAGE |
2 |
| 127 |
SYNCOPE |
2 |
| 128 |
TACHYPHYLAXIS |
2 |
| 129 |
THROMBOCYTOPENIA |
2 |
| 130 |
UNDERDOSE |
2 |
| 131 |
WITHDRAWAL HYPERTENSION |
2 |
| 132 |
ABDOMINAL DISTENSION |
1 |
| 133 |
ABNORMAL CLOTTING FACTOR |
1 |
| 134 |
ACCIDENTAL EXPOSURE |
1 |
| 135 |
ACIDOSIS |
1 |
| 136 |
ACQUIRED APPARENT MINERALOCORTICOID EXCESS |
1 |
| 137 |
ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED |
1 |
| 138 |
ACUTE CORONARY SYNDROME |
1 |
| 139 |
ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT |
1 |
| 140 |
ACUTE MYOCARDIAL INFARCTION |
1 |
| 141 |
ACUTE RESPIRATORY DISTRESS SYNDROME |
1 |
| 142 |
ACUTE RESPIRATORY FAILURE |
1 |
| 143 |
ADMINISTRATION SITE EXTRAVASATION |
1 |
| 144 |
AGITATION |
1 |
| 145 |
ALANINE AMINOTRANSFERASE INCREASED |
1 |
| 146 |
ANAPHYLACTIC REACTION |
1 |
| 147 |
ANGIOPATHY |
1 |
| 148 |
ANXIETY |
1 |
| 149 |
APNOEA |
1 |
| 150 |
ASPARTATE AMINOTRANSFERASE ABNORMAL |
1 |
| 151 |
ASPARTATE AMINOTRANSFERASE INCREASED |
1 |
| 152 |
AZOTAEMIA |
1 |
| 153 |
BASILAR ARTERY OCCLUSION |
1 |
| 154 |
BASILAR ARTERY THROMBOSIS |
1 |
| 155 |
BLOOD BILIRUBIN ABNORMAL |
1 |
| 156 |
BLOOD CHOLESTEROL INCREASED |
1 |
| 157 |
BLOOD HOMOCYSTEINE INCREASED |
1 |
| 158 |
BLOOD MAGNESIUM ABNORMAL |
1 |
| 159 |
BLOOD PHOSPHORUS ABNORMAL |
1 |
| 160 |
BLOOD POTASSIUM ABNORMAL |
1 |
| 161 |
BLOOD PRESSURE FLUCTUATION |
1 |
| 162 |
BLOOD SODIUM INCREASED |
1 |
| 163 |
BLOOD UREA INCREASED |
1 |
| 164 |
BRAIN STEM INFARCTION |
1 |
| 165 |
BUNDLE BRANCH BLOCK RIGHT |
1 |
| 166 |
CAESAREAN SECTION |
1 |
| 167 |
CARDIAC DISORDER |
1 |
| 168 |
CARDIAC FAILURE CONGESTIVE |
1 |
| 169 |
CARDIAC MURMUR |
1 |
| 170 |
CARDIAC SEPTAL DEFECT RESIDUAL SHUNT |
1 |
| 171 |
CARDIOPULMONARY FAILURE |
1 |
| 172 |
CAROTID ARTERY OCCLUSION |
1 |
| 173 |
CATHETER SITE INFLAMMATION |
1 |
| 174 |
CHEST PAIN |
1 |
| 175 |
CHILLS |
1 |
| 176 |
CHOLECYSTITIS ACUTE |
1 |
| 177 |
CIRCULATORY COLLAPSE |
1 |
| 178 |
COAGULOPATHY |
1 |
| 179 |
COLITIS |
1 |
| 180 |
COMPLICATION ASSOCIATED WITH DEVICE |
1 |
| 181 |
CONCOMITANT DISEASE AGGRAVATED |
1 |
| 182 |
CONFUSIONAL STATE |
1 |
| 183 |
CONVULSION |
1 |
| 184 |
CORONARY ARTERY BYPASS |
1 |
| 185 |
COVID-19 |
1 |
| 186 |
CRANIAL NERVE PALSIES MULTIPLE |
1 |
| 187 |
CYANOSIS |
1 |
| 188 |
CYTOKINE RELEASE SYNDROME |
1 |
| 189 |
CYTOPENIA |
1 |
| 190 |
DEHYDRATION |
1 |
| 191 |
DEMENTIA WITH LEWY BODIES |
1 |
| 192 |
DISORIENTATION |
1 |
| 193 |
DRUG DISPENSING ERROR |
1 |
| 194 |
DRUG DOSE TITRATION NOT PERFORMED |
1 |
| 195 |
DRUG EFFECTIVE FOR UNAPPROVED INDICATION |
1 |
| 196 |
DRUG EXPOSURE DURING PREGNANCY |
1 |
| 197 |
DRUG HYPERSENSITIVITY |
1 |
| 198 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
1 |
| 199 |
DRUG LABEL CONFUSION |
1 |
| 200 |
DRUG RESISTANCE |
1 |
| 201 |
DYSARTHRIA |
1 |
| 202 |
ECHOCARDIOGRAM ABNORMAL |
1 |
| 203 |
ELECTROCARDIOGRAM ABNORMAL |
1 |
| 204 |
ELECTROCARDIOGRAM ST SEGMENT DEPRESSION |
1 |
| 205 |
ELECTROCARDIOGRAM ST SEGMENT ELEVATION |
1 |
| 206 |
EMBOLIC STROKE |
1 |
| 207 |
EMBOLISM |
1 |
| 208 |
EPIGLOTTITIS |
1 |
| 209 |
EPILEPSY |
1 |
| 210 |
EYE ROLLING |
1 |
| 211 |
FEBRILE INFECTION |
1 |
| 212 |
FLUID OVERLOAD |
1 |
| 213 |
FOOD ALLERGY |
1 |
| 214 |
GASTRIC ULCER |
1 |
| 215 |
GENERALISED OEDEMA |
1 |
| 216 |
GLOMERULONEPHRITIS RAPIDLY PROGRESSIVE |
1 |
| 217 |
GRAFT COMPLICATION |
1 |
| 218 |
GROIN PAIN |
1 |
| 219 |
HAEMATOMA |
1 |
| 220 |
HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS |
1 |
| 221 |
HAEMOPTYSIS |
1 |
| 222 |
HAEMORRHAGE |
1 |
| 223 |
HEPATITIS B |
1 |
| 224 |
HYPERCALCAEMIA |
1 |
| 225 |
HYPERKALAEMIA |
1 |
| 226 |
HYPERSENSITIVITY |
1 |
| 227 |
HYPERTENSIVE EMERGENCY |
1 |
| 228 |
HYPERTENSIVE URGENCY |
1 |
| 229 |
HYPERVOLAEMIA |
1 |
| 230 |
HYPOKALAEMIA |
1 |
| 231 |
HYPOVOLAEMIA |
1 |
| 232 |
INCISION SITE PAIN |
1 |
| 233 |
INCORRECT DOSE ADMINISTERED BY DEVICE |
1 |
| 234 |
INCORRECT DRUG ADMINISTRATION DURATION |
1 |
| 235 |
INFARCTION |
1 |
| 236 |
INFECTION |
1 |
| 237 |
INFLAMMATORY MARKER INCREASED |
1 |
| 238 |
INFUSION SITE INDURATION |
1 |
| 239 |
INFUSION SITE PAIN |
1 |
| 240 |
INFUSION SITE PHLEBITIS |
1 |
| 241 |
INFUSION SITE PRURITUS |
1 |
| 242 |
INFUSION SITE VESICLES |
1 |
| 243 |
INFUSION SITE WARMTH |
1 |
| 244 |
INJECTION SITE ERYTHEMA |
1 |
| 245 |
INTERSTITIAL LUNG ABNORMALITY |
1 |
| 246 |
JARISCH-HERXHEIMER REACTION |
1 |
| 247 |
KETOSIS |
1 |
| 248 |
LABORATORY TEST INTERFERENCE |
1 |
| 249 |
LACTIC ACIDOSIS |
1 |
| 250 |
LEUKOCYTOSIS |
1 |
| 251 |
LEUKOPENIA |
1 |
| 252 |
LIPIDS INCREASED |
1 |
| 253 |
LIVER FUNCTION TEST ABNORMAL |
1 |
| 254 |
LIVER FUNCTION TEST INCREASED |
1 |
| 255 |
LUNG OPACITY |
1 |
| 256 |
MALAISE |
1 |
| 257 |
MALIGNANT NEOPLASM PROGRESSION |
1 |
| 258 |
MATERNAL EXPOSURE DURING PREGNANCY |
1 |
| 259 |
MEDICATION ERROR |
1 |
| 260 |
METHAEMOGLOBINAEMIA |
1 |
| 261 |
MYASTHENIA GRAVIS |
1 |
| 262 |
NEOPLASM PROGRESSION |
1 |
| 263 |
NEPHRITIC SYNDROME |
1 |
| 264 |
NODAL ARRHYTHMIA |
1 |
| 265 |
OBSTRUCTIVE SHOCK |
1 |
| 266 |
OCULAR ISCHAEMIC SYNDROME |
1 |
| 267 |
OEDEMA PERIPHERAL |
1 |
| 268 |
OPERATIVE HAEMORRHAGE |
1 |
| 269 |
ORGAN FAILURE |
1 |
| 270 |
PERIPHERAL COLDNESS |
1 |
| 271 |
PNEUMOCYSTIS JIROVECII PNEUMONIA |
1 |
| 272 |
POOR QUALITY DRUG ADMINISTERED |
1 |
| 273 |
POST PROCEDURAL HAEMORRHAGE |
1 |
| 274 |
PRESYNCOPE |
1 |
| 275 |
PROCEDURAL COMPLICATION |
1 |
| 276 |
PROCEDURAL HYPERTENSION |
1 |
| 277 |
PRODUCT ADMINISTRATION ERROR |
1 |
| 278 |
PRODUCT COLOUR ISSUE |
1 |
| 279 |
PRODUCT DOSAGE FORM CONFUSION |
1 |
| 280 |
PRODUCT NAME CONFUSION |
1 |
| 281 |
PRODUCT PACKAGING CONFUSION |
1 |
| 282 |
PRODUCT PHYSICAL ISSUE |
1 |
| 283 |
PROTEIN TOTAL ABNORMAL |
1 |
| 284 |
PRURITUS |
1 |
| 285 |
PSEUDOMONAS INFECTION |
1 |
| 286 |
PULMONARY ARTERY THROMBOSIS |
1 |
| 287 |
PULMONARY HAEMORRHAGE |
1 |
| 288 |
PULSE ABSENT |
1 |
| 289 |
PULSELESS ELECTRICAL ACTIVITY |
1 |
| 290 |
RENAL DISORDER |
1 |
| 291 |
RESPIRATORY DISORDER |
1 |
| 292 |
RESPIRATORY SYNCYTIAL VIRUS INFECTION |
1 |
| 293 |
RESTLESSNESS |
1 |
| 294 |
RHABDOMYOLYSIS |
1 |
| 295 |
SEPTIC SHOCK |
1 |
| 296 |
SERUM FERRITIN INCREASED |
1 |
| 297 |
STAPHYLOCOCCAL SEPSIS |
1 |
| 298 |
STRESS |
1 |
| 299 |
SUPRAVENTRICULAR TACHYCARDIA |
1 |
| 300 |
SWELLING FACE |
1 |
| 301 |
SWELLING OF EYELID |
1 |
| 302 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
1 |
| 303 |
THROMBOPHLEBITIS |
1 |
| 304 |
THROMBOSIS |
1 |
| 305 |
TOXICITY TO VARIOUS AGENTS |
1 |
| 306 |
TRANSAMINASES INCREASED |
1 |
| 307 |
TRANSIENT ISCHAEMIC ATTACK |
1 |
| 308 |
TREATMENT NONCOMPLIANCE |
1 |
| 309 |
TREMOR |
1 |
| 310 |
TROPONIN INCREASED |
1 |
| 311 |
ULCER |
1 |
| 312 |
URINARY LIPIDS PRESENT |
1 |
| 313 |
URINARY RETENTION |
1 |
| 314 |
VASCULAR RESISTANCE SYSTEMIC DECREASED |
1 |
| 315 |
VASCULITIS |
1 |
| 316 |
VASODILATATION |
1 |
| 317 |
VASOSPASM |
1 |
| 318 |
VENOUS OCCLUSION |
1 |
| 319 |
VENOUS OXYGEN SATURATION DECREASED |
1 |
| 320 |
VENOUS THROMBOSIS LIMB |
1 |
| 321 |
VENTRICULAR DYSFUNCTION |
1 |
| 322 |
VENTRICULAR TACHYCARDIA |
1 |
| 323 |
VOCAL FOLD IMMOBILITY |
1 |
| 324 |
VOMITING |
1 |
| 325 |
WEIGHT DECREASED |
1 |